|
2024
|
Invention
|
Primers and probes for detecting mycobacteria.
The present invention is directed to a set of pri... |
|
|
Invention
|
Flavivirus vaccine.
The present invention is directed to an artificial nucleic acid and to a pol... |
|
2023
|
Invention
|
Zika virus vaccine.
The present invention is directed to an artificial nucleic acid and to polyp... |
|
|
Invention
|
Compositions for booster vaccination against dengue.
The present invention is directed to a meth... |
|
|
Invention
|
Diagnostic tests.
The present invention provides an immunodiagnostic test device for the detecti... |
|
2022
|
Invention
|
Human cytomegalovirus immunogenic composition.
The invention relates to an immunogenic compositi... |
|
2021
|
Invention
|
Live-attenuated yellow fever virus strain adapted to grow on vero cells and vaccine composition c... |
|
|
Invention
|
Liposomes containing tlr4 agonist, preparation and uses thereof.
The present invention relates t... |
|
|
Invention
|
Internal cardboard support for receiving pharmaceutical products, packaging and method for packag... |
|
|
Invention
|
Lipidic compounds comprising at least one terminal radical of formula -nh-cx-a or -nh-cx-nh-a, co... |
|
|
Invention
|
Cleavable lipidic compounds, compositions containing thereof, and uses thereof.
The disclosure r... |
|
2020
|
Invention
|
Human cytomegalovirus immunogenic composition. The invention relates to an immunogenic compositio... |
|
|
Invention
|
Method for determining at a current time point a preservation state of one product and computer s... |
|
|
Invention
|
Liquid feeding device for the generation of droplets. The present invention provides, inter alia,... |
|
2019
|
Invention
|
Process line for the production of freeze-dried particles. A process line for the production of f... |
|
|
Invention
|
Heating device for rotary drum freeze-dryer. A heating device (124) for heating particles to be f... |
|
|
Invention
|
Ready-to-sell packaging unit containing at least one pharmaceutical product, set including a plur... |
|
2018
|
Invention
|
Flavivirus vaccine. The present invention is directed to an artificial nucleic acid and to a poly... |
|
|
Invention
|
Meningococcal vaccine based on lipooligosaccharide (los) originating from modified neisseria meni... |
|
|
Invention
|
Compositions for booster vaccination against dengue. The present invention is directed to a metho... |
|
|
Invention
|
Multimerization of recombinant protein by fusion to a sequence from lamprey. The present inventio... |
|
|
Invention
|
Vaccine compositions.
The present invention relates to vaccine compositions that are useful in a... |
|
2017
|
Invention
|
Detoxification method for lipopolysaccharide (lps) or lipid a of gram-negative bacteria.
The inv... |
|
|
Invention
|
Immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants. The pr... |
|
|
Invention
|
Neisseria meningitidis strains of immunotype l6. N. meningitidis, especially of serogroup B. |
|
|
Invention
|
Haemophilus influenzae type b antigens. Haemophilus influenzae type b (Hib) is cultured in a cult... |
|
|
Invention
|
Zika virus vaccine. The present invention is directed to an artificial nucleic acid and to polype... |
|
2016
|
Invention
|
S. aureus. The invention relates to a conjugate of a saccharide covalently bound to a carrier pro... |
|
|
Invention
|
Concomitant dengue and yellow fever vaccination. The present invention relates to a yellow fever ... |
|
|
Invention
|
Immunogenic compositions.
The present invention provides compositions comprising a Chlamydial ma... |
|
|
Invention
|
Process for stabilizing an adjuvant containing vaccine composition. The present invention relates... |
|
2015
|
Invention
|
N. meningitidis proteins. Neisseria meningitidis (Nm) protein antigens selected from the group co... |
|
|
Invention
|
Neisseria meningitidis trypsin-like serine protease polypeptides and compositions thereof.
The p... |
|
|
Invention
|
Meningitidis vaccines comprising subtilinases.
The present invention relates to novel polypeptid... |
|
|
Invention
|
Vaccine compositions against dengue virus diseases. The present invention relates to vaccine comp... |
|
|
Invention
|
Method of storing a vaccine containing an aluminum adjuvant. The invention relates to a method fo... |
|
|
Invention
|
Method for purifying the rabies virus. b) the virus is eluted from its support.
|
|
2014
|
Invention
|
Dengue serotype 2 attenuated strain.
The invention relates to live attenuated VDV2 (VERO-Derived... |
|
2013
|
Invention
|
Vaccination against japanese encephalitis, measles, mumps and rubella.
The invention relates to ... |
|
|
Invention
|
Production of infectious influenza viruses. The invention relates to a method for producing influ... |
|
|
Invention
|
Vaccine compositions for prevention against dengue virus infection.
The present invention relate... |
|
2012
|
Invention
|
Rotary drum for use in a vacuum freeze-dryer. A rotary drum (302) for use within a vacuum chamber... |
|
2003
|
P/S
|
Pharmaceutical preparations, namely, human vaccines for the treatment of diphtheria, tetanus, per... |
|
|
P/S
|
Pharmaceutical preparations, namely, human vaccines for the treatment of diphteria, tetanus, pert... |
|
2002
|
P/S
|
Pharmaceutical products and specialties, namely, vaccines for human use for use in the treatment ... |
|
2001
|
P/S
|
Pharmaceutical products, namely, human vaccines against hepatitis and typhoid fever. |
|
1999
|
P/S
|
Vaccin contre la grippe. |
|
1998
|
P/S
|
Produits pharmaceutiques, nommément: vaccins humains contre les maladies à pneumocoques. |
|
1995
|
P/S
|
Produits pharmaceutiques, nommément: vaccins à usage humain, vaccins contre la fièvre typhoïde.
P... |
|
|
P/S
|
Produits pharmaceutiques, nommément vaccins pour les humains. |
|
1992
|
P/S
|
Pharmaceuticals namely, an anti-haemophilia vaccine influenza type B; pharmaceutical products, na... |
|
1981
|
P/S
|
Immunoglobulines. |
